One triple-proficient patient with an intermediate TMB had amplifications of CCNE1 and ERBB2 in all tumor samples (>20 additional copies; Figure 1), supporting oncogene amplification as a driving mechanism in the absence of DNA damage repair deficiency (29, 30). The gene discussed is ERBB2; the disease is neoplasm.